Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 28;23(1):822.
doi: 10.1186/s12884-023-06113-3.

The yield of early-pregnancy homeostasis of model assessment -insulin resistance (HOMA-IR) for predicting gestational diabetes mellitus in different body mass index and age groups

Affiliations

The yield of early-pregnancy homeostasis of model assessment -insulin resistance (HOMA-IR) for predicting gestational diabetes mellitus in different body mass index and age groups

Sima Hashemipour et al. BMC Pregnancy Childbirth. .

Abstract

Background: Early prediction of gestational diabetes mellitus(GDM) can be beneficial for lifestyle modifications to prevent GDM. The aim of this study was to investigate the predictive values of Homeostasis of Model Assessment -Insulin Resistance (HOMA-IR) in early pregnancy to predict GDM development in different body mass index (BMI) and age risk categories.

Materials and methods: This study is part of the Qazvin Maternal and Neonatal Metabolic Study (QMNMS) in Iran (2018-2021). In this prospective longitudinal study, pregnant women with a gestational age ≤ 14 weeks were enrolled in the study using convenience sampling method and were followed up until delivery to investigate risk factors for maternal and neonatal complications. Data collection was done using questionnaires. Serum sampling was done at a gestational age ≤ 14 weeks and sera were frozen until the end of study. GDM was diagnosed at 24-28 weeks of pregnancy using 75gr oral glucose tolerance test. Fasting blood glucose and insulin were measured in sera taken during early pregnancy in 583 participants. The Mann-Whitney U test, independent t-test, and Chi-square test were used for comparing variables between groups. The logistic regression analysis was used to examine the independent association of HOMA-IR with GDM development and receiver operating characteristic analysis was used for finding the best cut-off of HOMA-IR for predicting GDM.

Results: GDM was developed in 90 (15.4%) of the participants. The third HOMA-IR tertile was independently associated with 3.2 times higher GDM occurrence (95% CI:1.6-6.2, P = 0.001). Despite the high prevalence of GDM in advanced maternal age (GDM rate = 28.4%), HOMA-IR had no association with GDM occurrence in this high-risk group. In both normal BMI and overweight/obese groups, HOMA-IR was a moderate predictor of GDM development (AUC = 0.638, P = 0.005 and AUC = 0.622, P = 0.008, respectively). However, the best cut-off for predicting GDM was 2.06 (sensitivity 67.5%, specificity 61.1%) in normal BMI and 3.13 (sensitivity 64.6%, specificity61.8%) in overweight/obese BMI.

Conclusion: The present study revealed the necessity of considering the BMI and age risk groups when using the HOMA-IR index to predict GDM. Using lower cut-offs is more accurate for women with a normal BMI. In the advanced maternal age, there is no yield of HOMA-IR for predicting GDM.

Keywords: Advanced maternal age; Body mass index; Gestational Diabetes Mellitus; HOMA-IR.

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no competing interests.

Figures

Fig. 1
Fig. 1
Receiver operating characteristic curve of HOMA-IR for prediction of GDM. A: total group, B: age<35y, C: BMI<25kg/m2, D: BMI≥25kg/m2; ROC: Receiver operating characteristic

Similar articles

Cited by

References

    1. - Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, Roura LC, McIntyre HD, Morris JL, Divakar H. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational Diabetes Mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynecol Obstet. 2015;131:173–211. doi: 10.1016/S0020-7292(15)30007-2. - DOI - PubMed
    1. - Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational Diabetes Mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med. 2012;25(6):600–10. doi: 10.3109/14767058.2011.587921. - DOI - PubMed
    1. - Saravanan P, Magee LA, Banerjee A, Coleman MA, Von Dadelszen P, Denison F, Farmer A, Finer S, Fox-Rushby J, Holt R, Lindsay RS. Gestational Diabetes: opportunities for improving maternal and child health. The Lancet Diabetes & Endocrinology. 2020;8(9):793–800. doi: 10.1016/S2213-8587(20)30161-3. - DOI - PubMed
    1. - Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational Diabetes Mellitus. Int J Mol Sci. 2018;19(11):3342. doi: 10.3390/ijms19113342. - DOI - PMC - PubMed
    1. - Zhu H, Chen B, Cheng Y, Zhou Y, Yan YS, Luo Q, Jiang Y, Sheng JZ, Ding GL, Huang HF. Insulin therapy for gestational Diabetes Mellitus does not fully protect offspring from Diet-Induced Metabolic disorders. Diabetes. 2019;68(4):696–708. doi: 10.2337/db18-1151. - DOI - PubMed

LinkOut - more resources